A link between the outcome of living unrelated kidney transplantation and HLA compatibility: A preliminary report

Archives of Medical Science

Volumn 3, Issue 2, 2007, Pages 108-111

  Pourfarziani, Vahid ^a   Einollahi, Behzad ^a   Assari, Shervin ^a   Kardavani, Babak ^a   Lankarani, Maryam Moghani ^a   Kalantar, Ebrahim ^a  

^a BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Graft survival; HLA; HLA compatibility; Kidney transplantation; Living donors

Indexed keywords

CYCLOSPORIN; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR3 ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FOLLOW UP; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HLA SYSTEM; HLA TYPING; HUMAN; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION;

EID: 34547804803     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Davis CL, Delmonico FL Living-donor kidney transplantation: a review of the current practices for the live donor. J Am Soc Nephrol 2005; 16: 2098-110.
2. Ghods AJ. Should we have live unrelated donor renal transplantation in MESOT countries? Transplant Proc 2003; 35: 2542-4.
3. Masri MA, Haberal MA, Shaheen FA, et al. Middle East Society for Organ Transplantation (MESOT) Transplant Registry. Exp Clin Transplant 2004; 2: 217-20.
4. Broumand B. Transplantation activities in Iran. Exp Clin Transplant 2005; 3: 333-7.
5. Ghods AJ. Renal transplantation in Iran. Nephrol Dial Transplant 2002; 17: 222-8.
6. Price D. Living kidney donation in Europe: legal and ethical perspectives - the EUROTOLD Project. Transpl Int 1994; 7 (suppl. 1): S665-7.
7. McAlister VC, Badovinac K. Transplantation in Canada: Report of the Canadian Organ Replacement Register. Transplant Proc 2003; 35: 2428-30.
8. Shiohira Y, Iseki K, Kowatari T, et al. A community-based evaluation of the effect of renal transplantation on survival in patients with renal-replacement therapy. Nippon Jinzo Gakkai Shi 1996; 38: 449-54.
9. Takemoto S, Port FK, Claas FH, Duquesnoy RJ. HLA matching for kidney transplantation. Hum Immunol 2004; 65: 1489-505.
10. Kalble T, Lucan M, Nicita G, et al. European Association of Urology. EAU guidelines on renal transplantation. Eur Ural 2005; 47: 156-66.
11. OPTN/SRTR Annual Report 2003. Table 5.9b. Available at: http://www.optn.org.
12. Cecka JM. The OPTN/UNOS Renal Transplant Registry. Clin Transpl 2003; 1-12.
13. Oellerich M, Armstrong VW, Kahan B, et al. Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel. Ther Drug Monit 1995; 17: 642-54.
14. Hwang SH, Oh HB, Shin ES, Yew M, Kim SC, Han DJ. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation. Transplant Proc 2005; 37: 4194-8.
15. Takemoto S, Port FK, Claas FH, Duquesnoy RJ. HLA matching for kidney transplantation. Hum Immunol 2004; 65: 1489-505.
16. Opelz G. Impact of HLA compatibility on survival of kidney transplants from unrelated live donors. Transplantation 1997; 64: 1473-5.
17. El-Agroudy AE, Bakr MA, Hassan NA, et al. Characteristics of long-term live-donor renal allograft survivors. Am J Nephrol 2003; 23: 165-71. Epub 2003 Mar 27.
18. Panigrahi A, Agarwal SK, Kanga U, et al. Influence of HLA compatibility on renal graft survival using live unrelated & cadaver donors in India Indian J Med Res 2002; 115:158-64.
19. Cecka JM. The UNOS Renal Transplant Registry. Clin Transpl 2002; 1-18.
20. Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333-6.
21. Oien CM, Reisaeter AV, Leivestad T, Dekker FW, Line PD, Os I. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes. Transplantation 2007; 83: 600-6.
22. Mizutani K, Terasaki P, Hamdani E, et al. Importance of Anti-HLA-Specific Antibody Strength in Monitoring Kidney Transplant Patients. Am J Transplant 2007; 7: 1027-31.
23. Allan JS, Madsen JC. Recent advances in the immunology of chronic rejection. Curr Opin Nephrol Hypertens 2002; 11: 315-21.
24. Gjertson DW. Look-up survival tables for living-donor renal transplants: OPTN/UNOS data 1995-2002. Clin Transpl 2003; 337-86.
25. Takada M, Nadeau KC, Shaw GD, Marquette KA, Tilney NL The cytokine-adhesion molecule cascade in ischemia/ reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand. J Clin Invest 1997; 99: 2682-90.
26. Gabolde M, Herve C, Moulin AM. Evaluation, selection, and follow-up of live kidney donors: a review of current practice in French renal transplant centres. Nephrol Dial Transplant 2001; 16: 2048-52.